BeOne Medicines Ltd.

NASDAQ: ONC · Real-Time Price · USD
321.57
11.88 (3.84%)
At close: Aug 15, 2025, 3:59 PM
321.00
-0.18%
After-hours: Aug 15, 2025, 07:27 PM EDT

BeOne Medicines Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
2.63B 3.17B 3.87B 4.38B
Short-Term Investments
n/a 2.6M 665.25M 2.24B
Long-Term Investments
128.93M 89.64M 91.78M 100.79M
Other Long-Term Assets
13.38M 33.17M 83.91M 30.65M
Receivables
709.11M 358.03M 173.17M 500.18M
Inventory
494.99M 416.12M 282.35M 242.63M
Other Current Assets
25.19M 166.61M 133.66M 128.71M
Total Current Assets
3.99B 4.2B 5.21B 7.61B
Property-Plant & Equipment
1.66B 1.42B 845.95M 686.74M
Goodwill & Intangibles
129.76M 57.14M 94.57M 103.46M
Total Long-Term Assets
1.93B 1.6B 1.17B 1.03B
Total Assets
5.92B 5.81B 6.38B 8.65B
Account Payables
405M 315.11M 294.78M 168.04M
Deferred Revenue
n/a n/a 213.86M 407.7M
Short-Term Debt
851.53M 688.37M 328.97M 427.56M
Other Current Liabilities
359.5M 195.97M 299.11M 353.34M
Total Current Liabilities
2.21B 1.81B 1.47B 1.6B
Long-Term Debt
166.48M 197.62M 209.15M 202.11M
Other Long-Term Liabilities
90.7M 187.27M 187.54M 558.25M
Total Long-Term Liabilities
373.79M 457.83M 527.41M 803.41M
Total Liabilities
2.59B 2.27B 2B 2.4B
Total Debt
1.08B 930.18M 596.67M 694.64M
Common Stock
138K 135K 135K 133K
Retained Earnings
-8.61B -7.96B -7.08B -4.97B
Comprehensive Income
-148.99M -99.45M -77.42M 17.95M
Shareholders Equity
3.33B 3.54B 4.38B 6.24B
Total Investments
128.93M 92.24M 757.03M 2.34B